Introduction: Treatment of several diseases of the brain are complicated by the presence of the skull and the blood-brain barrier (BBB). Focused ultrasound (FUS) and microbubble (MB)-mediated BBB treatment is a minimally invasive method to transiently increase the permeability of blood vessels in targeted brain areas. It can be used as a general delivery system to increase the concentration of therapeutic agents in the brain parenchyma.
Areas Covered: Over the past two decades, the safety of using FUS+MBs to deliver agents across the BBB has been interrogated through various methods of imaging, histology, biochemical assays, and behavior analyses. Here we provide an overview of the factors that affect the safety profile of these treatments, describe methods by which FUS+MB treatments are controlled, and discuss data that have informed the assessment of treatment risks.
Expert Opinion: There remains a need to assess the risks associated with clinically relevant treatment strategies, specifically repeated FUS+MB treatments, with and without therapeutic agent delivery. Additionally, efforts to develop metrics by which FUS+MB treatments can be easily compared across studies would facilitate a more rapid consensus on the risks associated with this intervention.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576291 | PMC |
| http://dx.doi.org/10.1080/17425247.2019.1567490 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effect of Microbubble Size, Composition, and Multiple Sonication Points on Sterile Inflammatory Response in Focused Ultrasound-Mediated Blood-Brain Barrier Opening.
ACS Biomater Sci Eng
December 2024
Biomedical Engineering Program, University of Colorado Boulder, Boulder, Colorado 80303, United States.
Blood-brain barrier opening (BBBO) using focused ultrasound (FUS) and microbubbles (MBs) has emerged as a promising technique for delivering therapeutics to the brain. However, the influence of various FUS and MB parameters on BBBO and subsequent sterile inflammatory response (SIR) remains unclear. In this study, we investigated the effects of MB size and composition, as well as the number of FUS sonication points, on BBBO and SIR in an immunocompetent mouse model.
View Article and Find Full Text PDFInvestigation of Sonication Parameters for Large-Volume Focused Ultrasound-Mediated Blood-Brain Barrier Permeability Enhancement Using a Clinical-Prototype Hemispherical Phased Array.
Pharmaceutics
September 2024
Physical Sciences Platform, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.
Article Synopsis
- Focused ultrasound (FUS) combined with microbubble (MB) exposure shows promise for targeted drug delivery to the brain, but further refinement for large-scale clinical applications is needed.
- Research involving rabbits demonstrated that continuous manual agitation of MBs during infusion improved blood-brain barrier (BBB) permeability more than gravity drip methods, with key sonication parameters influencing the outcome significantly.
- Overall, the study found that while enhancing BBB permeability, the risk of tissue damage remained low, indicating potential for safer and effective clinical protocols for this technique.
Safety and Efficacy of Axon Therapy (SEAT Study), Utilizing Magnetic Peripheral Nerve Stimulation (mPNS) for Treatment of Neuropathic Pain.
J Pain Res
September 2024
Department of Surgery, Pain Medicine Service, Charlie Norwood Veterans Administration Medical Center, Augusta, GA, USA.
Background: Many of the current treatments for chronic neuropathic pain have variable effectiveness and known side effects. Given the prevalence of this type of intractable pain (3-17% of general population), additional therapeutic non-invasive approaches are desired. Magnetic Peripheral Nerve Stimulation (mPNS) delivered at 0.
View Article and Find Full Text PDFA Transmit-Receive Phased Array for Microbubble-Mediated Focused Ultrasound Brain Therapy in Small Animals.
IEEE Trans Biomed Eng
September 2024
Unlabelled: Focused ultrasound (FUS) combined with circulating microbubbles (MBs) can be employed for non-invasive, localized agent delivery across the blood-brain barrier (BBB). Previous work has demonstrated the feasibility of clinical-scale transmit-receive phased arrays for performing transcranial therapies under MB imaging feedback.
Objective: This study aimed to design, construct, and evaluate a dual-mode phased array for MB-mediated FUS brain therapy in small animals.
Precision medicine focus on the central nervous system: Non-invasive therapeutic agent delivery with focused ultrasound and microbubbles.
Adv Cancer Res
September 2024
Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States; VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States; VCU Massey Comprehensive Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States. Electronic address:
Article Synopsis
- Focused ultrasound (FUS) paired with microbubble (MB) treatment shows great promise in delivering molecular medicines and gene therapy for various diseases, particularly for overcoming the blood-brain barrier (BBB) in CNS disorders.
- FUS is a non-invasive technique that enhances the delivery of therapeutic compounds into the brain, with potential applications in treating not just neurological disorders but also cancer and other medical conditions.
- Ongoing advancements in FUS and MB technologies aim to improve the precision and effectiveness of drug delivery, with the goal of integrating these methods into routine medical practices and enhancing patient care.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!